Olaparib, a drug that targets cancer cells with faulty genetic code, is on track to become the first-ever precision medicine for prostate cancer.
Friday, 4th October 2019
This is certainly worth a read - click here to view. It may have my name at the top (Dave) but just ignore it.
February 2021 Support Group Meeting
23 Feb 2021 18:30–20:00
April 2021 Support Group Meeting
6 Apr 2021 18:30–20:00
May 2021 Support Group Meeting
18 May 2021 18:30–20:00
June 2021 Support Group Meeting
29 Jun 2021 18:30–20:00
August 2021 Support Group Meeting
10 Aug 2021 18:30–20:00